AMY TRENTHAM-DIETZ, PHD, MS - Population Health … TRENTHAM-DIETZ, PHD, MS . PERSONAL DATA ... Amy...

AMY TRENTHAM-DIETZ, PHD, MS

PERSONAL DATA WARF Room 307 610 Walnut Street

Madison, WI 53726 Telephone: (608) 265-4175 Fax: (608) 265-5330 Email: [email protected]

EDUCATION 1997 PhD, Epidemiology University of Wisconsin, Madison, Wisconsin 1992 MS, Statistics with emphasis in Biostatistics University of Wisconsin, Madison, Wisconsin 1990 BS, Mathematics University of Puget Sound, Tacoma, Washington PRESENT POSITIONS AND APPOINTMENTS 2011-present Program Faculty Graduate Program in Epidemiology, University of Wisconsin, Madison, WI 2010-present Program Leader Cancer Control Research Program, Carbone Cancer Center, Madison, WI 2008-present Associate Professor University of Wisconsin Department of Population Health Sciences, Madison, WI 2007-present Member Institute for Clinical and Translational Research, University of Wisconsin, Madison, WI 2006-present Program Faculty Master of Public Health Program, School of Medicine and Public Health, University of

Wisconsin-Madison, WI 2005-present ex officio Member

Amy Trentham-Dietz, PhD 1

Wisconsin Cancer Council 2001-present Program Faculty Graduate Program in Population Health, University of Wisconsin-Madison 1999-present Member University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, WI PAST POSITIONS 2001-2007 Assistant Professor University of Wisconsin Department of Population Health Sciences (formerly Preventive

Medicine), Madison, WI 2000-2001 Associate Scientist University of Wisconsin Comprehensive Cancer Center, Madison, WI 1998-2000 Assistant Scientist University of Wisconsin Comprehensive Cancer Center, Madison, WI 1997-1998 Postdoctoral Trainee University of Wisconsin Comprehensive Cancer Center, Madison, WI PROFESSIONAL SOCIETY MEMBERSHIPS

1999-present American Society for Preventive Oncology 1998-present Society for Epidemiologic Research


HONORS AND AWARDS 2013 Research Committee Travel Award, Graduate School, University of Wisconsin 2010 Engage Digital Media Award, University of Wisconsin 2010 Teaching Academy Summer Institute Grant: Risk Taking in Teaching and Learning,

University of Wisconsin 2010 Mid-Career Women Faculty Professional Development Seminar, Association of

American Medical Colleges, Scottsdale, Arizona 2004 Teaching Academy Summer Institute Grant: Teaching and Learning in the New

Millennium, University of Wisconsin 2003-2004 Medical Education Development and Leadership Program: Art and Science of

Teaching, University of Wisconsin Medical School, Madison, WI 2000 Academic Staff Professional Development Award, University of Wisconsin 1998 Poster Award, Society for Epidemiologic Research 1996 New Investigator’s Workshop, American Society of Preventive Oncology 1990 Phi Beta Kappa Honor Society, University of Puget Sound RESEARCH SUPPORT Current Grant Support (check for effort levels that may have been higher) 2012-2017 Informatics Techniques to Optimize Mammography for Aging Populations Source: NIH R01 CA165229 Total direct costs: $1,500,000 Role: Co-investigator (B. Burnside, Principal Investigator) Effort: 0.6 calendar 2012-2014 Environmental Cadmium Exposure and Breast Density Source: Avon Foundation 02-2011-116 Total direct cost: $275,927 Role: Co-investigator (P. Newcomb, Principal Investigator) Effort: 0.12 calendar 2011-2016 Risk-Based Breast Cancer Screening in Community Settings Source: NIH P01 CA154292. Total direct costs: $20,164,518 Role: Co-investigator (D. Miglioretti and K. Kerlikowske, Principal Investigators) Effort: 0.84 calendar 2011-2016 Vermont PROSPR Research Center


Source: NIH U54 CA163303 Total direct costs: $4,704,388 Role: Project Leader (B. Sprague and D. Weaver, Principal Investigators) Effort: 1.2 calendar 2011-2014 Tumor Microenvironment and Progression to Invasion after a Diagnosis of

Ductal Carcinoma in situ Source: Congressionally Directed Medical Research (Breast Cancer) Program Idea

Award, W81XWH-11-0214 Total direct costs: $229,629 Role: Principal Investigator Effort: 1.2 calendar 2010-2015 Comparative Modeling: Informing Breast Cancer Control Practice and Policy Source: NIH U01 CA152958 Total direct costs: $4,908,145 Role: Co-Principal Investigator with J. Mandelblatt, D. Berry, S. Lee, S Plevritis, and

H. de Koning Effort: 1.2 calendar 2010-2015 Genetics of Breast Cancer Risk at Windows of Exposure Source: NIH U01 ES019466 Total direct costs $1,500,000. Role: Co-investigator (M. Gould, Principal Investigator) Effort: 0.96 calendar 2009-2014 Breast Carcinoma in situ: Predicting Risk and Outcomes Source: NIH R01 CA067264 Total direct costs: $2,440,427 Role: Principal Investigator Effort: 1.2 calendar Past Grant Support 2011-2012 Breast Cancer Task Force: Creating Change through Collaboration Source: Komen for the Cure Madison Affiliate, 2601188 Total direct costs: $43,478 Role: Principal Investigator Effort: 0.36 calendar


2010-2011 Tumor Microenvironment and Disease-Free Survival after a Diagnosis of

Ductal Carcinoma In Situ Source: University of Wisconsin Clinical and Type 1 Translational Research Pilot

Research Program Total direct costs: $37,495 Role: Principal Investigator Effort: 0.12 calendar 2009-2012 The Vitamin D Pathway and Mammographic Breast Density in Postmenopausal

Women Source: NIH R03 CA139548 Total direct costs: $100,000 Role: Principal Investigator 2009-2012 Reducing Cancer Health Disparities through Comprehensive Cancer Control Source: Wisconsin Division of Public Health, UWCCC, and the Wisconsin Partnership

Program for a Healthy Future (Blue Cross Program) Total direct costs: $770,079 Role: Co-investigator (J. Cleary, Principal Investigator) 2009-2010 Co-morbidities in Relation to Patient-Oriented Outcomes Source: NIH P30 CA014520 (Pilot Project) Total direct costs: $24,542 Role: Principal Investigator 2008-2013 Breast Cancer GWAS: Function and Environmental Interactions Source: NIH R01 ES017400 Total direct costs $435,373 Role: Co-investigator (M. Gould and M. Newton, Principal Investigators) Effort: 0.36 calendar 2007-2010 Age of First Birth and Breast Cancer Histology Source: Avon Foundation Total direct costs: $97,109 Role: Co-investigator (P. Newcomb, Principal Investigator) 2009-2010 Obesity & the Quality of Breast and Prostate Cancer Care

Source: NIH P30 CA14520 (Pilot Project) Total direct costs: $35,841

Role: Principal Investigator


2007-2011 Total Xenoestrogen Body Burden in Relation to Mammographic Density, A

Marker of Breast Cancer Risk Source: Congressionally Directed Medical Research (Breast Cancer) Program

Synergistic Idea Award W81XWH-07-1-0522 Total direct costs: $364,490 Role: Principal Investigator 2007-2010 Xenoestrogens, Sex Hormones, and Breast Density Source: Susan G. Komen for the Cure Breast Cancer Foundation FAS0703857 Total direct costs: $172,341 Role: Principal Investigator 2007-2010 Using the UWBCS to Assess Racial Disparities in Breast Cancer Incidence &

Survival Source: NIH R03 CA130727 Total direct costs: $100,000 Role: Co-investigator (O. Alagoz, Principal Investigator) 2005-2010 Wisconsin Cancer Registry Evaluation: Patterns of Care Study Source: NIH/CDC U01 DP000261 Total direct costs: $668,553 Role: Co-investigator (J.F. Wilson, Principal Investigator) 2005-2008 Quality of Life Before and After a Diagnosis of Breast Cancer in Older Women Source: Susan G. Komen Breast Cancer Foundation POP0504237 Total direct costs: $199,980 Role: Principal Investigator 2005-2007 Physical Activity, Pain and Function in Cancer Survivors Source: NIH P20 CA103697 Total direct costs: $23,300 Role: Co-investigator (R. Weindruch, PI/L. Colbert, Project Leader) 2005-2007 Influence of Diet and Lifestyle on Breast Cancer Outcome Source: Susan G. Komen Breast Cancer Foundation POP0504234 Total direct costs: $188,261 Role: Co-investigator (P. Newcomb, Principal Investigator) 2005-2007 Comprehensive Cancer Control in Wisconsin: Translating Research into

Practice


Source: Wisconsin Division of Public Health, UWCCC, and the Wisconsin Partnership

Program for a Healthy Future (Blue Cross Program) Total direct costs: $789,200 Role: Co-investigator (G. Wilding, Principal Investigator) 2004-2007 Gene Interactions, Estrogen, and Risk of Breast Cancer Source: NIH R01 CA105197 Total direct costs: $1,111,503 Role: Co-investigator (K.M. Egan, Principal Investigator) 2004-2006 Cadmium Exposure and Breast Cancer Risk Source: NIH R03 CA110796 Total direct costs: $100,000 Role: Co-investigator (J.A. McElroy, Principal Investigator) 2002-2009 Medications, Genetic Variability & Breast Cancer Source: NIH R01 CA047147 Total direct costs: $2,058,824 Role: Co-Principal Investigator with P. Newcomb 2002-2005 SES, Environmental Factors and Colorectal Cancer Risk

Source: NIH R03 CA099504 Total direct costs: $100,000

Role: Principal Investigator 2002-2007 Breast Cancer in situ: Recurrence and Quality of Life

Source: NIH R01 CA67264 Total direct costs: $1,250,000

Role: Principal Investigator 2001-2002 Collecting DNA from a Case-Control Study for Genomic Analysis

Total direct costs: $19,410 Source: NIH P30 CA14520 (Pilot Project) Role: Co-Principal Investigator with M. Gould

2000-2005 Simulating Breast Cancer in Wisconsin Source: NIH U01 CA088211 Total direct costs: $600,000 Role: Co-investigator (D. Fryback, Principal Investigator) 1999-2004 Regional Variation of Breast Cancer Rates in Wisconsin


Source: NIH U01 CA82004 Total direct costs: $797,849 Role: Co-investigator (P.L. Remington, Principal Investigator) 1999-2000 A Feasibility Study of Determinants of Menarche Source: Cancer Research Foundation of America and the American Society of

Preventive Oncology Cancer Prevention Fellowship Total direct costs: $30,000 Role: Principal Investigator 1999-2000 Quality of Life in Female Colorectal Cancer Survivors Source: NIH R03 CA078977 Total direct costs: $100,000 Role: Project Director (P.L. Remington, Principal Investigator) 1998 A Feasibility Study of Determinants of Menarche Source: NIH P30 CA14520 (Pilot Project) Total direct costs: $14,000 Role: Principal Investigator PUBLICATIONS IN REFEREED JOURNALS M Mentored by the candidate. Underlined names indicate candidate’s student as first author. 1. Hart McLaughlin V, Trentham-Dietz A, Hampton JM, Newcomb PA, Sprague BL. Lifestyle

factors and the risk of a second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev (in press).

2. Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and

cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiologic Rev 36(1): 114-36, 2014.

3. Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA. Modification of breast cancer risk according to age and menopausal status: A combined analysis of five population-based case-control studies. Breast Cancer Res Treat (in press).

4. Warren Andersen SM, Trentham-Dietz A, Gangnon RE, Hampton JM, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA. Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan.


Cancer Epidemiol 38(10: 62-5, 2014. 5. Batina NG, Trentham-Dietz A, Gangnon RE, Sprague BL, Rosenberg MA, Stout NK,

Fryback DG, Alagoz O. Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis. Breast Cancer Res Treat 138(2): 519-28, 2013.

6. Cetnar JPM, Hampton JM, Williamson AA, Downs T, Wang D, Owen JB, Crouse B, Jones N,

Wilson JF, Trentham-Dietz A. Place of residence and primary treatment of prostate cancer: examining trends in rural and nonrural areas of Wisconsin. Urology 81(3): 540-547, 2013.

7. Halverson JM, Walsh MC, Strickland J, Smith P, Palta M, Cleary J, Trentham-Dietz A,

Martinez-Donate A. Health literacy and urbanicity among cancer patients. J Rural Health 29(4): 392-402, 2013.

8. Martinez-Donate AP, Halverson J, Simon NJ, Strickland JS, Trentham-Dietz A, Smith PD,

Linskens R, Wang X. Identifying health literacy and health system navigation needs among rural cancer patients: findings from the Rural Oncology Literacy Enhancement Study (ROLES). J Cancer Educ 28(3): 573-81, 2013.

9. Newcomb PA, Kampman E, Trentham-Dietz A, Egan KM, Titus L, Baron JA, Hampton JM,

Passarelli MN, Willett WC. Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol 31(16): 1939-46, 2013.

10. Nichols HBM, Trentham-Dietz A, Newcomb PA, Egan KM, Titus LJ, Hampton JM, Visvanathan K. Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer. Breast Cancer Res 15(5): R99, 2013.

11. Nichols S et al (96 authors including Trentham-Dietz). Evidence of gene-environment

interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet 9(3): e1003284, 2013.

12. Sprague BLM, McLaughlin V, Hampton JM, Newcomb PA, Trentham-Dietz A. Disease-free

survival by treatment after a DCIS diagnosis in a population-based cohort study. Breast Cancer Res Treat 141(1): 145-54, 2013.

13. Sprague BLM, Trentham-Dietz A, Hedman CJ, Wang J, Hemming JD, Hampton JM, Buist

DS, Aiello Bowles EJ, Sisney GS, Burnside ES. Circulating serum xenoestrogens and mammographic breast density. Breast Cancer Res 15(3): R45, 2013.

14. Thraen-Borowski KMM, Trentham-Dietz A, Edwards DF, Koltyn KF, Colbert LH. Dose-


response relationships between physical activity, social participation, and health-related quality of life in colorectal cancer survivors. J Cancer Surviv 7(3): 369-78, 2013.

15. Wang J, Trentham-Dietz A, Hemming JD, Hedman CJ, Sprague BL. Serum factors and

clinical characteristics associated with serum E-screen activity. Cancer Epidemiol Biomarkers Prev 22(5): 962-71, 2013.

16. Warren Anderson SM, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton

JM, Egan KM, Newcomb PA. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. Menopause 20(3): 354-8, 2013.

17. Warren Andersen SM, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner

HG, Engelman CD, Klein BE, Titus LJ, Newcomb PA. The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk. Breast Cancer Res Treat 140(2): 427-34, 2013.

18. Fleming ST, Kimmick GG, Sabatino SA, Cress RD, Wu XC, Trentham-Dietz A, Huang B,

Hwang W, Liff JM; Patterns of Care Study Group. Defining care provided for breast cancer based on medical record review or Medicare claims: information from the Centers for Disease Control and Prevention Patterns of Care Study. Ann Epidemiol 22(11): 807-13, 2012.

19. Hein R et al (168 authors including Trentham-Dietz). Comparison of 6q25 breast cancer hits

from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One 7(8): e42380, 2012.

20. Higginbotham KS, Breyer JP, McReynolds KM, Bradley KM, Schuyler PA, Plummer WD,

Freudenthal ME, Trentham-Dietz A, Newcomb PA, Parl FF, Sanders ME, Page DL, Egan KM, Dupont WD, Smith JR. A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24. Cancer Epidemiol Biomarkers Prev 21(9): 1565-73, 2012.

21. Lowry SJ, Sprague BL, Aiello Bowles EJ, Hedman CJ, Hemming J, Hampton JM, Burnside

ES, Sisney GA, Buist DS, Trentham-Dietz A. Mammographic breast density and serum phytoestrogen levels. Nutr Cancer 64(6): 783-9, 2012.

22. Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O’Meara ES, Buist DSM, Kerlikowske K,

van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL. Risk factors for breast cancer for women aged 40-49 years: a systematic review and meta-analysis. Ann Intern Med 156(9): 635-648, 2012.

23. Nichols HBM, Trentham-Dietz A, Newcomb PA, Titus LJ, Egan KM, Hampton JM,


Visvanathan K. Post-oophorectomy estrogen use and breast cancer risk. Obstet Gynecol 120(1): 27-36, 2012.

24. Schumacher JRM, Palta M, LoConte NK, Trentham-Dietz A, Witt WP, Heidrich SM, Smith

MA. Characterizing the psychological distress response before and after a cancer diagnosis. J Behav Med (in press).

25. Schumacher JRM, Witt WP, Palta M, LoConte NK, Heidrich SM, Trentham-Dietz A, Pandhi

N, Smith MA. Cancer screening of long-term cancer survivors. J Am Board Fam Med 25(4): 460-9, 2012.

26. Sprague BLM, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal

hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol 120(3): 595-603, 2012.

27. Sprague BLM, Trentham-Dietz A, Gangnon RE, Buist DS, Burnside ES, Aiello Bowles EJ,

Stanczyk FZ, Sisney GS, Skinner HG. The vitamin D pathway and mammographic breast density among postmenopausal women. Breast Cancer Res Treat 131(1): 255-65, 2012.

28. Van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DSM, Huang H,

Heijnsdijk EAM, Trentham-Dietz A, Alagoz A, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years. Ann Intern Med 156(9): 609-617, 2012.

29. Walsh MCM, Trentham-Dietz A, Gangnon RE, Nieto FJ, Newcomb PA, Palta M. Selection

bias in population-based cancer case-control studies due to incomplete sampling frame coverage. Cancer Epidemiol Biomarkers Prev 21(6): 881-6, 2012.

30. Walsh MCM, Trentham-Dietz A, Newcomb PA, Gangnon R, Palta M. Using propensity scores

to reduce case-control selection bias. Epidemiology 23(5): 772-3, 2012. 31. Warren Andersen SM, Newcomb PA, Hampton JM, Titus LJ, Egan KM, Trentham-Dietz A.

Parity and mortality from causes other than breast cancer in breast cancer patients - response. Breast Cancer Research Treat 131(3):1080-81, 2012.

32. Warren Andersen SM, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton

JM, Egan KM, Newcomb PA. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. Menopause 20(3): 354-358, 2013.

33. Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, Fleming ST,


Morris CR, Huang B, Trentham-Dietz A, Lipscomb J. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol 30(2): 142-50, 2012.

34. Warren Andersen SM S, Newcomb PA, Hampton JM, Titus-Ernstoff L, Egan KM, Trentham-

Dietz A. Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res Treat 130(3):975-80, 2011.

35. Sprague BLM, Trentham-Dietz A, Gangnon RE, Ramchandani R, Hampton JM, Robert SA,

Remington PL, Newcomb PA. Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer 117(7): 1542-51, 2011.

36. German RR, Wike JM, Bauer KR, Fleming ST, Trentham-Dietz A, Namiak M, Almon L,

Knight K, Perkins C for the Patterns of Care Study Group. Quality of cancer registry data: findings from CDC-NPCR’s Breast and Prostate Cancer Data Quality and Patterns of Care Study. J Registry Manage 38(2):75-86, 2011.

37. Walsh MCM, Trentham-Dietz A, Palta M. Availability of driver’s license master lists for use in

government-sponsored public health research. Am J Epidemiol 173(12): 1414-8, 2011. 38. Higginbotham KS, Breyer JP, Bradley KM, Schuyler PA, Plummer WD Jr, Freudenthal ME,

Trentham-Dietz A, Newcomb PA, Sanders ME, Page DL, Parl FF, Egan KM, Dupont WD, Smith JR. A multistage association study identifies a breast cancer genetic locus at NCOA7. Cancer Res 71(11): 3881-8, 2011.

39. Cai Q, Wen W, Qu S, Li G, Egan KM, Chen K, Deming SL, Shen H, Shen CY, Gammon

MD, Blot WJ, Matsuo K, Haiman CA, Khoo US, Iwasaki M, Santella RM, Zhang L, Fair AM, Hu Z, Wu PE, Signorello LB, Titus-Ernstoff L, Tajima K, Henderson BE, Chan KY, Kasuga Y, Newcomb PA, Zheng H, Cui Y, Wang F, Shieh YL, Iwata H, Le Marchand L, Chan SY, Shrubsole MJ, Trentham-Dietz A, Tsugane S, Garcia-Closas M, Long J, Li C, Shi J, Huang B, Xiang YB, Gao YT, Lu W, Shu XO, Zheng W. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of Chinese, Japanese, and European ancestry. Cancer Res 71(4): 1344-1355, 2011.

40. Figueroa JD, Garcia-Closas M, Humphreys M, et al. Associations of common variants at

1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 20(23): 4693-706, 2011.

41. Fleming ST, Sabatino SA, Kimmick G, Cress R, Wu X-C, Trentham-Dietz A, Huang B,

Hwang W, Liff J for the Patterns of Care Study Group. Developing a claims-based version of


the ACE-27 comorbidity index: a comparison with medial record review. Med Care 49(8): 752-60, 2011.

42. Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Bersch AJ, Passarelli MN,

Holick CN, Titus-Ernstoff L, Egan KM, Holmes MD, Willett WC. Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat 128(1): 229-36, 2011.

43. Nichols HBM, Visvanathan K, Newcomb PA, Hampton JM, Egan KM, Titus-Ernstoff L,

Trentham-Dietz A. Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery? Am J Epidemiol 173(10): 1111-20, 2011.

44. Newcomb PA, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Warren

Andersen S, Greenberg ER, Willett WC. Late age at first full term birth is strongly associated with lobular breast cancer. Cancer 117(9): 1946-56, 2011.

45. Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA. Use of antidepressants and

NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol Drug Saf 20(2): 131-137, 2011.

46. Sprague BLM, Remington PL, Trentham-Dietz A. The contribution of postmenopausal

hormone use cessation to the declining incidence of breast cancer. Cancer Causes Control 22(1): 125-134, 2011. PMCID: PMC3034386.

47. Sprague BLM, Trentham-Dietz A, Gangnon RE, Buist DSM, Burnside ES, Aiello Bowles EJ,

Stanczyk FZ, Sisney GS. Circulating sex hormones and mammographic breast density among postmenopausal women. Hormones and Cancer 2:62-72, 2011. PMCID: PMC3035325.

48. Kramer, BJ, Kavanaugh M, Trentham-Dietz A, Walsh M, Yonker JA. Complicated grief

symptoms in caregivers of persons with lung cancer: the role of family conflict, intrapsychic strains, and hospice utilization. Omega (Westport) 62(3): 201-220, 2010-2011.

49. Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Ceballos RM, Titus-Ernstoff

L, Egan KM, Holmes MD. Social networks and survival after breast cancer diagnosis. J Cancer Surviv 4(4): 372-80, 2010. PMCID: PMC2978785.

50. Kramer BJ, Kavanaugh M, Trentham-Dietz A, Walsh M, Yonker JA. Predictors of family

conflict at the end of life: the experiences of spouses and adult children of persons with lung cancer. Gerontologist 50(2): 215-25, 2010. PMCID: PMC2904531.


51. Sprague BLM, Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA. Change in

lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ. Breast Cancer Res Treat 124(2): 487-495, 2010. PMCID: PMC2924938.

52. Klein BEK, Lee KE, Moss SE, Trentham-Dietz A, Klein R. Self and registry reported cancer

in a population-based longitudinal study. Wis Med J 109(5): 261-266, 2010. 53. Sprague BLM, Trentham-Dietz A, Burnside BS. Socioeconomic disparities in the decline in

invasive breast cancer incidence. Breast Cancer Res Treat 122(3): 873-878, 2010. PMCID: PMC2904433.

54. Newcomb PA, Trentham-Dietz A, Hampton JM. Bisphosphonates for osteoporosis treatment

are associated with reduced breast cancer risk. Br J Cancer 102(5): 799-802, 2010. PMCID: PMC2833248.

55. Walsh MCM, Trentham-Dietz A, Schroepfer TA, Reding DJ, Campbell B, Foote ML,

Kaufman S, Barrett M, Remington PL, Cleary JF. Cancer information sources used by patients to inform and influence treatment decisions. J Health Communication 15(4): 445-63, 2010.

56. Anic GM, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Egan KM. Sleep duration and

obesity in a population-based study. Sleep Med 11(5): 447-451, 2010. PMCID: PMC2854876.

57. Peterson NB, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Huang

Y, Chanock SJ, Haines JL, Egan KM. Association of COMT haplotypes and breast cancer risk in Caucasian women. Anticancer Res 30(1): 217-220, 2010.

58. Sprague BLM, Skinner HG, Trentham-Dietz A, Lee KE, Klein BE, Klein R. Serum calcium

and breast cancer risk in a prospective cohort study. Ann Epidemiol 20(1): 82-5, 2010. PMCID PMC2796253.

59. Sprague BLM, Trentham-Dietz A. Prevalence of breast carcinoma in situ in the United States.

JAMA 302(8): 846-848, 2009. PMCID PMC2884369. 60. Meulepas JM, Newcomb PA, Burnett-Hartman AN, Hampton JM, Trentham-Dietz A.

Multivitamin supplement use and risk of invasive breast cancer. Public Health Nutr 3: 1-6, 2009. PMCID: PMC2923261.

61. Nichols HBM, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ,

Holick CN, Hampton JM, Stampfer MJ, Willett WC, Newcomb PA. Body mass index before and after breast cancer diagnosis: Associations with all-cause, breast cancer, and cardiovascular


disease mortality. Cancer Epidemiol Biomarkers Prev 18(5): 1403-1409, 2009. PMCID: PMC2715918.

62. Wise LA, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Trichopoulos D, Hampton JM,

Egan KM. Exposure to breast milk in infancy and the risk of breast cancer. Cancer Causes Control 20(7): 1083-1090, 2009.

63. Huang Y, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton

JM, Chanock SJ, Haines JL, Egan KM. Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women. Cancer Epidemiol Biomarkers Prev 18(4): 1321-1323, 2009. PMCID: PMC2692636.

64. Johnson BLM, Trentham-Dietz A, Koltyn KF, Colbert LH. Physical activity and function in

older, long-term colorectal cancer survivors. Cancer Causes Control 20(5): 775-784, 2009. PMCID: PMC2716661.

65. Mignone LI, Govannucci EL, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton

JM, Willett WC, Stampfer MJ, Egan KM. Dietary carotenoids and the risk of invasive breast cancer. Int J Cancer 124(12): 2929-2937, 2009.

66. Newcomb PA, Chia VM, Hampton JM, Doria-Rose VP, Trentham Dietz A. Hormone

therapy in relation to survival from large bowel cancer. Cancer Causes Control 20(4): 409-416, 2009. PMCID: PMC2728675.

67. Gaudet MM, Milne RL, Cox A, et al on behalf of the Breast Cancer Association Consortium.

Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 18(5): 1610-1616, 2009. PMCID: PMC2737177.

68. Shadman M, Newcomb PA, Hampton JM, Wernli KJ, Trentham-Dietz A. Non-steroidal

anti-inflammatory drugs and statins in relation to colorectal cancer risk. World J Gastroenterol 15(19): 2336-2339, 2009. PMCID: PMC2684598.

69. Chubak J, Bowles EJ, Terry MB, Trentham-Dietz A, Buist DSM. Antidepressant medications

and change in mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 18(2): 676-679, 2009. PMCID: PMC2640441.

70. Wernli K, Newcomb PA, Trentham-Dietz A, Hampton JM. Antidepressant medication use

and breast cancer risk. Pharmacoepidemiol Drug Saf 18(4): 284-290, 2009. PMCID: PMC2720762.


71. Newcomb PA, Nichols HB, Beasley JM, Egan KM, Titus-Ernstoff L, Hampton JM,

Trentham-Dietz A. No difference between red wine and white wine consumption and breast cancer risk. Cancer Epidemiol Biomarkers Prev 18(3): 1007-1010, 2009. PMCID: PMC2710299.

72. Mignone LI, Govannucci EL, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton

JM, Orav EJ, Willett WC, Stampfer MJ, Egan KM. Meat consumption, heterocyclic amines, NAT2 and the risk of breast cancer. Nutr Cancer 61(1): 36-46, 2009.

73. Kumar N, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Anic G, Egan KM. Tea

consumption and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 18(1): 341-5, 2009.

74. Peterson NB, Huang Y, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Anic G, Egan

KM. Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 17(11): 3284-3287, 2008. PMCID: PMC2674789.

75. Kirchhoff AC, Newcomb PA, Trentham-Dietz A, Nichols HB, Hampton JM. Family history

and colorectal cancer survival in women. Familial Cancer 7(4): 287-292, 2008. 76. Sprague BLM, Andersen SWM, Trentham-Dietz A. Thyroid cancer incidence and

socioeconomic indicators of health care access. Cancer Causes Control 19(6): 585-593, 2008. 77. Sprague BLM, Trentham-Dietz A, Terry MB, Buist DM. Fertility drug use and mammographic

breast density in a mammography screening cohort of premenopausal women. Cancer Epidemiol Biomarkers Prev 17(11): 3128-3133, 2008.

78. Sprague BLM, Trentham-Dietz A, Klein BE, Klein R, Cruickshanks KJ, Lee KE, Hampton

JM. Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study. Cancer Epidemiol Biomarkers Prev 17(10): 2714-2722, 2008.

79. Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Hormone therapy

and ovarian cancer: incidence and survival. Cancer Causes Control 19(6): 605-613, 2008. 80. Sprague BLM, Trentham-Dietz A, Egan LM, Titus-Ernstoff L, Hampton JM, Newcomb PA.

Proportion of postmenopausal invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol 168(4): 404-11, 2008.

81. McElroy JA, Trentham-Dietz A, Hampton JM, Bersch AJ, Gangnon RE, Kanarek MS,

Newcomb PA. Nitrogen-nitrate exposure from drinking water and colorectal cancer risk for rural women in Wisconsin, USA. J Water Health 6(3): 399-409, 2008.


82. Terry MB, Buist DSM, Trentham-Dietz A, James-Todd TM, Liao Y. Nonsteroidal anti-

inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 women. Cancer Epidemiol Biomarkers Prev 17(5): 1088-1095, 2008.

83. Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Inverse association

of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Br J Cancer 98(11): 1781-1783, 2008.

84. Trentham-Dietz A, Sprague BL, Klein R, Klein BEK, Cruickshanks KJ, Fryback DG,

Hampton JM. Health-related quality of life before and after a breast cancer diagnosis. Breast Cancer Res Treat 109(2): 379-387, 2008.

85. Nichols HBM, Trentham-Dietz A, Sprague BL, Hampton JM, Titus-Ernstoff L, Newcomb

PA. Effects of birth order and maternal age on breast cancer risk: modification by whether women had been breast-fed. Epidemiology 19(3): 417-423, 2008.

86. Newcomb PA, Egan KM, Trentham-Dietz A, Titus-Ernstoff L, Baron JA, Hampton JM,

Stampfer M, Willett WC. Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev 17(4): 864-871, 2008.

87. Holick CN, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Bersch A, Stampfer MJ,

Holmes MD, Baron JA, Egan KM, Willett WC. Physical activity: survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 18(2): 379-386, 2008.

88. Pocobelli G, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM.

Statin use and risk of breast cancer. Cancer 112:27-33, 2008.

Prior to Promotion to Associate Professor with Tenure 89. Trentham-Dietz A, Nichols HB, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA.

Cigarette smoking and risk of breast carcinoma in situ. Epidemiology 18: 629-638, 2007. 90. Nichols HBM, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA.

Oral contraceptive use and risk of breast carcinoma in situ. Cancer Epidemiol Biomarkers Prev 16:2262-2268, 2007.

91. Sprague BLM, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L,

Hampton JM, Chanock SJ, Haines JL, Egan KM. Genetic variation in TP53 and risk of breast cancer in a population-based case-control study. Carcinogenesis 28: 1680-1686, 2007.


92. Trentham-Dietz A, Newcomb PA, Hampton JM. Breast cancer risk factors and second

primary malignancies among women with breast cancer. Breast Cancer Res Treat 105(2): 195-207, 2007.

93. McElroy JA, Gangnon RE, Newcomb PA, Kanarek ME, Anderson HA, VandenBrook J,

Trentham-Dietz A, Remington PL. Risk of breast cancer for women living in rural areas from adult exposure to atrazine from well water in Wisconsin. J Expo Sci Enviro Epidemiol 17: 207-214, 2007.

94. Detjen MGM, Nieto FJ, Trentham-Dietz A, Fleming M, Chasen-Tabar L. Acculturation and

cigarette smoking among pregnant Hispanic women residing in the United States. Am J Public Health 97: 2040-2047, 2007.

95. Sprague BLM, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hampton JM, Egan KM.

Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev 16(2): 236-243, 2007.

96. Liang X, Trentham-Dietz A, Titus-Ernstoff L, Newcomb PA, Welch RA, Hutchinson AA,

Hampton JM, Sutcliffe CB, Haines JL, Egan KM. Whole genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer. Cancer Epidemiol Biomarkers Prev 16(8): 1610-1614, 2007.

97. Samuelson DJ, Hesselson SE, Aperavich BA, Zan Y, Haag JD, Trentham-Dietz A, Hampton

JM, Mau B, Chen KS, Baynes C, Khaw KT, Luben R, Perkins B, Shah M, Pharoah PD, Dunning AM, Easton DF, Ponder BA, Gould MN. Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk. Proc Natl Acad Sci U S A 104(15): 6299-6304, 2007.

98. Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM. Obesity, diabetes, and other

factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer 17(2): 441-446, 2007.

99. Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, Yeager M,

Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M. Genetic variation of tumor necrosis factor-alpha and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 121(3-4):483-490, 2007.

100. McElroy JM, Trentham-Dietz A, Titus-Ernstoff L, Egan KM, Hampton JM, Newcomb PA.

Occupational exposure to electromagnetic fields and breast cancer risk in a large population-based case-control study in the United States. J Occup Enviro Med 49(3): 266-274, 2007.


101. McElroy JA, Shafter MM, Trentham-Dietz A, Hampton JM, Newcomb PA. Urinary

cadmium levels and tobacco smoke exposure in women age 20-69 years in the United States. J Toxicol Environ Health A 70: 1779-1782, 2007.

102. McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA. Cadmium

exposure and breast cancer risk. J Natl Cancer Inst 98(12): 869-873, 2006. 103. Yasui Y, Newcomb PA, Trentham-Dietz A, Egan KM. Familial relative-risk estimates for use

in epidemiologic analyses. Am J Epidemiol 164(7): 697-705, 2006. 104. Bandi PM, Dranger E, Hampton JM, Trentham-Dietz A. Trends in childhood cancer incidence

in Wisconsin, 1980-1999. Wis Med J 105(7):30-37, 2006. 105. Stout NKM, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG.

Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst 98(11): 774-782, 2006.

106. Burnside ES, Trentham-Dietz A, Kelcz F, Collins J. An example of breast cancer regression

on imaging. Radiology Case Reports 1(2): 27-37, 2006. 107. Nichols HBM, Trentham-Dietz A, Hampton JM, Titus-Ernstoff L, Egan KM, Willett WC,

Newcomb PA. From menarche to menopause: trends among U.S. women born 1912 to 1969. Am J Epidemiology 164(10): 1003-1011, 2006.

108. Fryback DF, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL.

The Wisconsin Breast Cancer Epidemiology Simulation Model. J Natl Cancer Inst Monogr 36:37-47, 2006.

109. Nichols HBM, Trentham-Dietz A, Newcomb PA, Yanke L, Remington PL, Love RR. What

causes cancer? Reports from sixth-grade girls. J Cancer Educ 21(3): 142-146, 2006. 110. Peterson NB, Trentham-Dietz A, Newcomb PA, Chen Z, Hampton JM, Willett WC, Egan

KM. Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer 119(10): 2423-2427, 2006.

111. Doria-Rose VP, Newcomb PA, Morimoto LM, Hampton JM, Trentham-Dietz A. Body

mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women. Cancer Causes Control 17(1): 63-70, 2006.

112. McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Egan KM.

Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep


Res 15: 241-249, 2006. 113. Peterson NB, Trentham-Dietz A, Newcomb PA, Chen Z, Gebretsadik T, Hampton JM,

Stampfer MJ, Willett WC, Egan KM. Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study. Cancer Causes Control 17(4): 459-467, 2006.

114. Morimoto LM, Newcomb PA, Hampton J, Trentham-Dietz A. Cholecystectomy and

endometrial cancer—a marker of long-term elevated estrogen exposure? Int J Gynecol Cancer 16(3): 1348-1353, 2006.

115. Trentham-Dietz A, Nichols NB, Newcomb PA, Hampton JM. Weight change and risk of

endometrial cancer. Int J Epidemiology 35(1): 151-158, 2006. 116. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS,

Yakovlev AY, Habbema DF, Feuer EJ for the Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N England J Med 353: 1784-1792, 2005.

117. Trentham-Dietz A, Nichols HB, Remington PL, Yanke L, Hampton JM, Newcomb PA,

Love RR. Correlates of menarche among sixth-grade students in Wisconsin. Wis Med J 104(7):65-69, 2005.

118. Nichols HM, Trentham-Dietz A, Hampton JM, Newcomb PA. Oral contraceptive use,

reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev 14:1212-1218, 2005.

119. Nichols HM, Trentham-Dietz A, Love RR, Hampton JM, Ahn PTH, Allred DC, Mohsin SK,

Newcomb PA. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Cancer Epidemiol Biomarkers Prev 14:41-47, 2005.

120. Nelson SEM, Gould MN, Hampton JM, Trentham-Dietz A. A case-control study of the

HER2 Ile655Val polymorphism in relation to risk of breast cancer. Breast Cancer Res 7:R357-R364, 2005.

121. Robert SA, Strombom I, Trentham-Dietz A, Hampton JM, McElroy JA, Newcomb PA,

Remington PL. Individual-level and community-level socioeconomic correlates of breast cancer incidence. Epidemiology 15:442-450, 2004.


122. Egan KM, Newcomb PA, Ambrosone CB, Trentham-Dietz A, Titus-Ernstoff L, Hampton

JM, Kimura M, Nagase H. STK15 polymorphism and breast cancer risk in a population-based study. Carcinogenesis 25:2149-2153, 2004.

123. McElroy JA, Kanarek MS, Trentham-Dietz A, Robert, SA, Hampton JM, Newcomb PA,

Anderson HA, Remington PL. Potential exposure to PCBs, DDT, and PBDEs from sport-caught fish consumption in relation to breast cancer risk in Wisconsin. Environ Health Perspect 112:156-162, 2004.

124. Anderson L, Remington PL, Trentham-Dietz A. Community trends in the early detection of

breast cancer, 1980-1988. Am J Prev Med 26:51-55, 2004. 125. Sapp ALM, Trentham-Dietz A, Hampton JM, Newcomb PA, Moinpour CM, Remington PL.

Social networks and quality of life among female long-term colorectal cancer survivors. Cancer 98:1749-1758, 2003.

126. Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE,

Longnecker MP, Baron JA, Daling JR. Oral contraceptive use and risk of breast cancer by histologic type. Int J Cancer 106:961-964, 2003.

127. Trentham-Dietz A, Remington PL, Moinpour CM, Hampton JM, Sapp AL, Newcomb PA.

Health-related quality of life in female long-term colorectal cancer survivors. The Oncologist 8:342-349, 2003.

128. McElroy JA,

Remington PL,

Trentham-Dietz A,

Robert SA,

Newcomb PA. Geocoding addresses from a large population-based study: lessons learned. Epidemiology 14:399-407, 2003.

129. Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE,

Longnecker MP, Baron JA, Daling JR. Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control 14:225-233, 2003.

130. Egan KM, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Mignone LI, Farin F, Hunter

DJ. Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case-control study (United States). Cancer Causes Control 14:43-51, 2003.

131. Newcomb PA, Trentham-Dietz A. Patterns of postmenopausal progestin use with estrogen

and endometrial cancer. Cancer Causes Control 14:195-201, 2003.


132. Leong NM, Mignone LI, Newcomb PA, Titus-Ernstoff L, Baron JA, Trentham-Dietz A,

Stampfer MJ, Willett WC, Egan KM. Early life risk factors in cancer: the relation of birth weight to adult obesity. Int J Cancer 103:789-791, 2003.

133. Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, Egan KM. Vitamin D receptor

polymorphism, hormones and breast cancer risk. Cancer Epidemiology Biomarkers Prev 11:1503-1504, 2002.

134. McElroy JA, Newcomb PA, Trentham-Dietz A, Hampton JM, Kanarek MS, Remington PL.

Endometrial cancer incidence in relation to electric blanket use. Am J Epidemiol 156:262-267, 2002.

135. Newcomer LM, Newcomb PA, Trentham-Dietz A, Storer BE, Yasui Y, Daling JA, Potter

JD. Detection method and breast cancer histology. Cancer 95:470-477, 2002. 136. Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett

WC, Stampfer M. Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiology Biomarkers Prev 11:593-600, 2002.

137. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA. Prevalence and

treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Mange 23:501-509, 2002.

138. Andersen LD, Remington P, Trentham-Dietz A, Reeves M. Assessing a decade of progress

in cancer control. The Oncologist 7:200-204, 2002. 139. Titus-Ernstoff L, Egan KM, Newcomb PA, Ding J, Trentham-Dietz A, Greenberg ER, Baron

JA, Trichopoulos D, Willett WC. Early life factors in relation to breast cancer risk in postmenopausal women. Cancer Epidemiology Biomarkers Prev 11:207-210, 2002.

140. McElroy J, Newcomb PA, Remington PL, Egan KM, Titus-Ernstoff L, Trentham-Dietz A,

Hampton J, Baron JA, Stampfer MJ, Willett WC. Electric blanket or mattress cover use and breast cancer incidence in women 50-79 years of age. Epidemiology 12:613-617, 2001.

141. Newcomer LM, Newcomb PA, Trentham-Dietz A, Storer BE. Hormonal risk factors for

endometrial cancer: modification by cigarette smoking (United States). Cancer Causes Control 12:829-835, 2001.

142. Newcomb PA, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Baron JA, Storer BE, Willett

WC, Stampfer M. Fracture history and risk of breast and endometrial cancer. Am J Epidemiol 153:1071-1078, 2001.


143. Newcomb PA, Trentham-Dietz A. Breast feeding practices in relation to endometrial cancer.

Cancer Causes Control 11:663-667, 2000. 144. Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL. Risk factors for carcinoma in

situ of the breast. Cancer Epidemiol Biomarkers Prev 9:697-703, 2000. 145. Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Baron JA, Storer BE,

Stampfer M, Willett WC. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 11:533-542, 2000.

146. Shoff SM, Newcomb PA, Trentham-Dietz A, Remington PL, Mittendorf R, Greenberg ER,

Willett WC. Early life physical activity and postmenopausal breast cancer: effect of body size and weight change. Cancer Epidemiol Biomarkers Prev 9:591-595, 2000.

147. Chie W-C, Hsieh C-C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp

RW, Burke KP, Titus-Ernstoff L, Trentham-Dietz A, MacMahon B. Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 7:715-722, 2000.

148. Egan KM, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Baron JA, Willett WC,

Stampfer MJ, Trichopoulos D. The relation of breast size to breast cancer risk in postmenopausal women (United States). Cancer Causes Control 10:115-117, 1999.

149. Newcomb PA, Taylor J, Trentham-Dietz A. Interactions of familial and hormonal risk factors

for large bowel cancer in women. Int J Epidemiol 28:603-608, 1999. 150. Newcomb PA, Egan KM, Titus-Ernstoff L, Trentham-Dietz A, Greenberg ER, Baron J,

Willett WC, Stampfer MJ. Lactation in relation to postmenopausal breast cancer. Am J Epidemiol 150:174-182, 1999.

151. Egan KM, Stampfer MJ, Rosner BA, Trichopoulos D, Newcomb PA, Trentham-Dietz A,

Longnecker MP, Mittendorf R, Greenberg ER, Willett WC. Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomarkers Prev 7:359-364, 1998.

152. Coogan PF, Newcomb PA, Clapp RW, Trentham-Dietz A, Baron JA, Longnecker MP.

Physical activity in usual occupation and risk of breast cancer (United States). Cancer Causes Control 8:626-631, 1997.

153. Newcomb PA, Trentham-Dietz A, Storer BE. Alcohol consumption in relation to endometrial

cancer risk. Cancer Epidemiol Biomarkers Prev 6:775-778, 1997.


154. Trentham-Dietz A, Newcomb PA, Storer BE, Longnecker MP, Baron J, Greenberg ER,

Willett WC. Body size and risk of breast cancer. Am J Epidemiol 145:1011-1019, 1997. 155. Newcomb PA, Trentham-Dietz A, Storer BE. Parental age in relation to risk of breast cancer.

Cancer Epidemiol Biomarkers Prev 6:151-154, 1997. 156. Reeves MJ, Newcomb PA, Trentham-Dietz A, Remington PL. Nonsteriodal anti-

inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 5:955-960, 1996.

157. Newcomb PA, Longnecker MP, Storer BE, Mittendorf R, Baron J, Clapp RW, Trentham-

Dietz A, Willett WC. Recent oral contraceptive use and risk of breast cancer. Cancer Causes Control 7:525-532, 1996.

158. Egan KM, Newcomb PA, Longnecker MP, Trentham-Dietz A, Baron JA, Trichopoulos D,

Stampfer MJ, Willett WC. Jewish religion and risk of breast cancer. Lancet 347:1645-1646, 1996.

159. Roberts F, Newcomb PA, Trentham Dietz A. Self reported stress and risk of breast cancer.

Cancer 77:1089-1093, 1996. 160. Mittendorf R, Longnecker MP, Newcomb PA, Trentham Dietz A, Greenberg ER, Bodgan

GF, Clapp RW, Willett WC. Strenuous physical activity in young adulthood and risk of breast cancer. Cancer Causes Control 6:347-354, 1995.

161. Trentham Dietz A, Newcomb PA, Storer BE, Longnecker MP, Mittendorf R. Multiple births

and risk of breast cancer. Int J Cancer 62:162-164, 1995. 162. Trentham Dietz A, Newcomb PA, Marcus PM, Storer BE. The association of body size and

large bowel cancer risk in Wisconsin women. Cancer Causes Control 6:30-36, 1995. NON-REFEREED PUBLICATIONS 1. Mandelblatt JS, Stout N, Trentham-Dietz A. To screen or not to screen women in their 40s

for breast cancer: is personalized risk-based screening the answer? Ann Intern Med 155(1): 58-60, 2011.

2. Trentham-Dietz A. Epidemiologic breast cancer research at the UW-Madison: A summary of

past accomplishments and future directions. Wis Med J 108(5): 284-285, 2009.


Prior to Promotion to Associate Professor with Tenure 3. Trentham-Dietz A, Buist DS, Kelly KM, Jacobson JS, Paskett E, ASPO Survivorship

Interest Group. Charting a strategic direction for the American Society of Preventive Oncology’s Survivorship Interest Group. Cancer Epidemiol Biomarkers Prev 16: 1912-1913, 2007.

4. Buist DS, Kanetsky PA, Studts JL, Li L, Terry MB, Trentham-Dietz A, Chang S. Recruiting and training leadership through professional societies: a report from the American Society of Preventive Oncology Junior Members Interest Group. Cancer Epidemiol Biomarkers Prev 15(7): 1422-1424, 2006.

5. Chang S, Buist DSM, Reid M, Terry MB, Trentham-Dietz A. The characteristics and training of professionals in cancer prevention and control: a survey of the American Society for Preventive Oncology. Cancer Epidemiol Biomarkers Prev 13: 1094-1098, 2004.

6. Remington PL, Trentham-Dietz A. Measuring progress in cancer control: a bird’s eye view. Oncologist 8:539-40, 2003.

BOOK CHAPTERS 1. Sprague BL, Trentham-Dietz A. In situ Breast Cancer. In: Breast Cancer Epidemiology, Li CI

(ed), New York: Springer, 2010: 47-72. 2. Trentham-Dietz A, Love RR, Newcomb PA. Population-based prevention strategies. In:

Management of Patients at High Risk for Breast Cancer, Vogel VG (ed), Massachusetts: Blackwell Science, 2001:277-94.

3. Love RR, Newcomb PA, Trentham-Dietz A. Prevention of breast cancer. In: Cancer of the

Breast, 5th ed, Donegan WL and Spratt JS (eds), Philadelphia: WB Saunders, 2002:199-223. BOOK REVIEW

Trentham-Dietz A. Review of: Breast Cancer Screening, Ismail J (ed), New York: Chapman & Hall, 1997. New England J Med 337:1564-1565, 1997.

PUBLISHED ABSTRACTS 1. (San Antonio)

2. McLaughlin V, Trentham-Dietz A, Hampton JM, Newcomb PA, Sprague BL. Lifestyle


factors and the risk of a second breast cancer diagnosis after DCIS in the Wisconsin In Situ Cohort. Cancer Epidemiol Biomarkers Prev 22(3): 472, 2013.

3. Warren Andersen SM, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA. Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan. Cancer Epidemiol Biomarkers Prev 22(3): 478, 2013.

4. Binder AM, Hampton J, Sprague B, Walsh M, Friedl A, Newcomb P, Trentham-Dietz A.

tumor markers in relation to disease-free survival among women with ductal carcinoma in situ of the breast. Am J Epidemiol 177(11 Suppl): S121, 2013.

5. Sprague BLM, Trentham-Dietz A, Cronin K. A sustained decline in postmenopausal hormone use: results from NHANES 1999-2010. Am J Epidemiol 173(Suppl): S135, 2012.

6. Gangnon RE, Sprague B, Stout N, Alagoz O, Trentham-Dietz A. Age-period-cohort analysis

of invasive breast cancer incidence in the United States, 1935-2008. Am J Epidemiol 175(Suppl):S6, 2012.

7. Warren Andersen SM, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Garcia-Closas M, Skinner HG, Engelman CE, Klein BE, Titus-Ernstoff L, Egan KM, Newcomb PA. Critical intervals of susceptibility, genetic loci and breast cancer risk. American Journal of Epidemiology 173(Suppl): S8, 2012.

8. Sprague BM, Trentham-Dietz A, Hedman C, Hemming J, Hampton J, Buist D, Aiello Bowles E, Burnside E, Sisney G. The association of serum phthalates and parabens with mammographic breast density. Cancer Epidemiol Biomarkers Prev 20:718, 2011.

9. Sprague BM, McLaughlin V, Hampton J, Newcomb P, Trentham-Dietz A. DCIS disease-free survival in the population-based Wisconsin In Situ Cohort. Cancer Prevention Research 4(10 Suppl): A28, 2011.

10. Newcomb PA, Kampman E, Trentham-Dietz A, Passarelli MN, Egan KM, Titus-Ernstoff L, Hampton JM, Willett WC. Alcohol consumption and survival after breast cancer. Am J Epidemiol 173(Suppl):S67, 2011.

11. Sprague BLM, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Remington PL, Newcomb PA. Variation in breast cancer risk by model of detection. Am J Epidemiol 173(Suppl):S251, 2011.

12. Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti D, Nelson H, Titus-Ernstoff L, Egan KM, Remington PL, Newcomb PA. Are risk factors for breast cancer in women <50


years of age different than for women over 50? Am J Epidemiol 173(Suppl):S256, 2011.

13. Walsh MCM, Trentham-Dietz A, Newcomb PA, Gangnon R, Palta M. An assessment of the use of propensity scores to reduce selection bias resulting from the use of a sampling frame with incomplete coverage of the study base to select controls. Am J Epidemiol 173(Suppl):S273, 2011.

14. Nichols HM, Trentham-Dietz A, Newcomb P, Titus-Ernstoff L, Egan K, Hampton J, Remington P, Visvanathan K. Breast cancer risk according to estrogen use after complete hysterectomy. Am J Epidemiol 171(Suppl):S23, 2010.

15. Gangnon RE, Trentham-Dietz A, Remington P, McElroy JA, Hampton J, Newcomb PA.

Geographic location and breast cancer risk. Am J Epidemiol 171(Suppl):S23, 2010. 16. Andersen SM, Trentham-Dietz A, Figueroa J, Garcia-Closas M, Titus-Ernstoff L, Hampton

JM, Egan KM, Newcomb PA, Cai Q, Long J. The relation between invasive breast cancer risk and FGFR2 does not vary by hormone therapy use. Am J Epidemiol 171(Suppl):S111, 2010.

17. Sprague BLM, Trentham-Dietz A, Gangnon RE, Buist DSM, Burnside ES, Aiello Bowles EJ,

Sisney GS. Circulating sex hormones and mammographic breast density among postmenopausal women. Am J Epidemiol 171(Suppl):S118, 2010.

18. Sprague BLM, Ramchandani R, Trentham-Dietz A, Newcomb P, Gangnon R, Remington PL,

Hampton JM. Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev 19(3):892, 2010.

19. Gangnon RE, Trentham-Dietz A. From case-control to cohort. Am J Epidemiol 169:S84,

2009. 20. Walsh MCM, Trentham-Dietz A, Bautista LE, Schaeffer NC, Nieto FJ, Newcomb PA.

Driver’s License Sampling Frame Coverage: Bias Caused By Opting-Out. Am J Epidemiol 169:S114, 2009.

21. Andersen SWM, Trentham-Dietz A, Engelman CD, Skinner HG, Garcia-Closas M, Titus-

Ernstoff L, Hampton JM, Newcomb PA, Egan KM. Polymorphisms in CYP1A1, CYP1A2, CYP1B1, IL6R, and TNF in Relation to Breast Cancer Survival. Am J Epidemiol 169:S4, 2009.

22. Warren Andersen SM, Newcomb PA, Hampton JM, Titus-Ernstoff L, Egan KM, Trentham-

Dietz A. Age at first birth and breast cancer histology in relation to mortality. Am J Epidemiol 169:S130, 2009.


23. Walsh MM, Trentham-Dietz A. Assessment of cancer care and satisfaction in Wisconsin:

focus on rural cancer patients. Surveillance Brief, UW Paul P. Carbone Comprehensive Cancer Center 5(2):1-4, 2009.

24. Walsh MCM, Trentham-Dietz A. Number of sources used by cancer patients to inform

treatment decisions according to socioeconomic status. Am J Epidemiol 167(Suppl): S58, 2008.

25. Klein BEK, Lee KE, Trentham-Dietz A, Klein R. Self-reported vs registry recorded cancers

in a longitudinal population-based study. Am J Epidemiol 167(Suppl): S61, 2008. 26. Sprague BLM, Trentham-Dietz A, Klein BEK, Klein R, Cruickshanks KJ, Lee K, Hampton J.

Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study. Cancer Epidemiol Biomarkers Prev 17(2): 461, 2008.

Prior to Promotion to Associate Professor with Tenure

27. Newcomb PA, Egan KM, Trentham-Dietz A, Titus-Ernstoff L, Baron JA, Hampton JM,

Wong EY, Stampfer MJ, Willett WC. Postmenopausal hormone use and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev 16(2):361, 2007.

28. Walsh MCM, Trentham-Dietz A, Newcomb PA. Characteristics of comedo type ductal

carcinoma in situ (DCIS) of the breast in relation to reproductive factors and molecular markers. Am J Epidemiol 165 (Suppl): S33, 2007.

29. Sprague BLM, Trentham-Dietz A, Newcomb PA, Hampton JM, Titus-Ernstoff L, Egan KM.

Population attributable fraction of breast cancer in postmenopausal women. Am J Epidemiol 165 (Suppl): S59, 2007.

30. Walsh MCM, Trentham-Dietz A, Hampton JM, Remington PL. Lifetime dog ownership,

urbanicity, and risk of breast cancer. Am J Epidemiol 165 (Suppl): S146, 2007. 31. Wernli KJ, Newcomb PA, Trentham-Dietz A, Hampton JM, Wong EY, Egan KM. Duration

and type of postmenopausal hormone use and ovarian cancer. Cancer Epidemiol Biomarkers Prev 16(2):361, 2007.

32. Trentham-Dietz A. Carcinoma in situ of the breast: true precursor or marker of increased risk? Am J Epidemiol 165 (Suppl): S97, 2007.

33. Trentham-Dietz A, Newcomb P, Titus-Ernstoff L, Egan K. Weight gain and risk of carcinoma

in situ of the breast. Am J Epidemiol 163(11):S98, 2006.


34. Terry MB, James TM, Trentham-Dietz A, Buist DM. NSAIDs and mammographic density.

Am J Epidemiol 163(11):S102, 2006. 35. Sprague BLM, Trentham-Dietz A, Egan KM, Hampton JM, Titus-Ernstoff L, Newcomb PA.

Lifetime recreational physical activity and breast cancer risk. Am J Epidemiol 163(11):S95, 2006.

36. Pocobelli G, Newcomb P, Trentham-Dietz A, Titus-Ernstoff L, Hampton J, Egan K. Statin

use and the risk of breast cancer. Am J Epidemiol 163(11):S37, 2006. 37. Nichols HM, Trentham-Dietz A, Hampton J, Newcomb P. Birth order, maternal age and

breast cancer risk among breastfed women. Am J Epidemiol 163(11):S100, 2006. 38. Liang X, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Garcia-Closas M, Welch RA,

Hutchinson AA, Hampton JM, Sutcliffe CB, Haines JL, Egan KM. Whole genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer. Proc AACR 47:550, 2006.

39. Egan KM, Trentham-Dietz A, Chanock S, Newcomb P, Welch R, Titus-Ernstoff L, Haines J,

Hampton J, Garcia-Closas M. Genetic variation in CYP1A1, CYP 1A2, and CYP1B1 and risk of invasive breast cancer in a US population-based case-control study. Proc AACR 47:1263, 2006.

40. Trentham-Dietz A, Garcia-Closas M, Sprague BL, Newcomb PA, Titus-Ernstoff L,

Hampton JM, Chanock SJ, Egan KM. Genetic variation in TP53 and risk of breast cancer in a population-based case-control study. Proc AACR 47:1266, 2006.

41. Trentham-Dietz A, Sprague BL, Klein R, Klein BEK, Cruickshanks KJ, Fryback DG, Hampton JM, Moss S, Knudtson M, Lee KE. Quality of life before and after a breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev 15(2):411, 2006.

42. Samuelson DJ, Nelson SE, Aperavich BA, Haag JD, Trentham-Dietz A, Mau R, Gardner

LL, Hampton JM, Pharoah PD, Shah M, Luben RN, Dunning A, Ponder BA, Gould MN. The human chromosome 9 region orthologous to Mcs5a, a rat composite modifier locus, contains a breast cancer risk allele. Proc AACR 47:1268, 2006.

43. Chia V, Trentham-Dietz A, Hampton J, McElroy J, Morimoto L, Newcomb P. Calcium

supplements and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 547, 2005. 44. McElroy JA, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM.

Breast cancer risk associated with electromagnetic field exposure from computer work ascertained from occupational history data. Epidemiology 16: S99-S100, 2005.


45. Trentham-Dietz A, Klein R, Klein BEK, Cruickshanks KJ, Hampton JM, Moss S, Lee KE.

Physical activity, body size, and lung cancer risk. Am J Epidemiol 161: S12, 2005. 46. Newcomb PA, Nichols HB, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan K.

Wine consumption and breast cancer risk. Am J Epidemiol 161: S56, 2005. 47. McElroy JA, Remington PL, Robert SA, Hampton JM, Trentham-Dietz A. Exploration of

residential history and breast cancer risk in Wisconsin using geographic information systems. Am J Epidemiol 159: S38, 2004.

48. Doria-Rose VP, Hampton JM, Trentham-Dietz A, Morimoto LM, Newcomb PA. Body

mass index and mortality following colorectal cancer in postmenopausal women. Am J Epidemiol 159: S68, 2004.

49. Strombom IMM, Smith MA, Trentham-Dietz A, Remington PL, Newcomb PA. Cancer care

capacity and out-of-area care utilization among urban and rural women with breast cancer. Am J Epidemiol 159: S37, 2004.

50. Trentham-Dietz A, Hampton JM, Newcomb PA. Risk of second cancers according to body mass index among breast cancer survivors. Am J Epidemiol 159: S70, 2004.

51. Trentham-Dietz A, Remington P, Robert S, Gangnon R, Hampton J, McElroy J, Newcomb

P. Geographic location, established risk factors and breast cancer risk. Am J Epidemiol 157:S41, 2003.

52. Garcia-Closas M, Egan K, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Rutter J, Hill

D, Brinton LA, Struewing J. Polymorphisms in DNA double strand break repair genes and risk of breast cancer in a population-based study. Proc AACR 44:1248, 2003.

53. Strombom IM, Smith M, Remington P, Trentham-Dietz A, Robert S. Contextual determinants

of mortality in women diagnosed with breast cancer. Am J Epidemiol 157:S46, 2003. 54. Morimoto L, Janes H, Trentham-Dietz A, Newcomb P. Menstrual factors and risk of

endometrial cancer. Am J Epidemiol 157:S12, 2003. 55. McElroy JA, Trentham-Dietz A, Kanarek MS, Robert SA, Hampton JM, Remington PL.

Exposure to plasticizers and breast cancer risk. Am J Epidemiol 157:S24, 2003. 56. Hampton JM, Trentham-Dietz A, Robert SA, Newcomb PA, McElroy JA, Remington PL.

Occupational physical activity and breast cancer risk. Am J Epidemiol 157:S38, 2003.


57. Sapp ALM, Trentham-Dietz A, Hampton JM, Robert SA, Newcomb PA, Remington PL.

Women’s working conditions and breast cancer risk. Am J Epidemiol 157:S95, 2003. 58. Sapp ALM, Trentham-Dietz A, Hampton JM, Robert SA, Newcomb PA, Remington PL.

Cancer Epidemiol Biomarkers Prev 12:182, 2003. 59. McElroy JA, Gangnon RE, Trentham-Dietz A, Newcomb PA, Remington PL. Using

geostatistics to assess atrazine exposure in a population-based case control study of breast cancer. Proc ISEA/ISEE, August 14, 2002, p. 169.

60. Morimoto L, Newcomb P, Trentham-Dietz A, Hampton J. Cholecystectomy and risk of

endometrial cancer. Am J Epidemiol 155:S12, 2002. 61. Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Storer BE, Baron JL,

Stampfer MJ, Willett WC. Survival after breast cancer according to pre-diagnosis weight in postmenopausal women. Am J Epidemiol 153:S110, 2001.

62. Hampton JM, Newcomb PA, Trentham-Dietz A, Storer BE. Survival of women with

colorectal cancer according to smoking history. Am J Epidemiol 153:S118, 2001. 63. McElroy JA, Newcomb PA, Trentham-Dietz A, Hampton JM, Remington PL. Endometrial

cancer incidence associated with electric blanket or mattress cover use. Am J Epidemiol 153:S111, 2001.

64. Trentham-Dietz A, Klein BEK, Klein R, Lee KE, Cruickshanks KJ, Newcomb PA.

Hormone levels and bone loss in older women. Am J Epidemiol 153:S27, 2001. 65. Newcomb PA, Kim HS, Trentham-Dietz A, Egan KM, Farin FM, Stampfer MJ. Vitamin D

receptor polymorphisms in relation to breast cancer risk. Proc Am Assoc Cancer Res 42:341, 2001.

66. McElroy JA, Andersen LD, Trentham-Dietz A, Kirby RS, Clayton MK, Remington PL.

Assigning atrazine exposure levels in a case-control study using spatial analysis of well water testing data. Am J Epidemiol 153:130, 2001.

67. Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Willett WC,

Stampfer MJ. Estrogen-progestin use in relation to risk of lobular and ductal breast cancer. Am J Epidemiol 151:S64, 2000.

68. Newcomb PA, Trentham-Dietz A. Progestin use with estrogen in relation to endometrial

cancer risk. Am J Epidemiol 151:S64, 2000.


69. Trentham-Dietz A, Remington PL, Newcomb PA, Love RR. Characteristics of menarche

among sixth-graders. Am J Epidemiol 151:S11, 2000.

70. Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Baron JA, Stampfer MJ, Willett WC. Recreational physical activity and risk of breast cancer. Am J Epidemiol 151:S67, 2000.

71. Newcomb PA, Storer BE, Trentham-Dietz A. Sigmoidoscopy and incidence and mortality

from colorectal cancer in women. Am J Epidemiol 151:S20, 2000. 72. Trentham-Dietz A, Love RR, Newcomb PA. Premenopausal breast cancer risk factors in

Vietnamese women. Cancer Epidemiol Biomarkers Prev 9:236, 2000. 73. Russell A, Langlois T, Johnson G, Trentham-Dietz A, Remington P. Increasing gap in breast

cancer mortality between black and white women. Wis Med J 99(6):34-36, 1999. 74. Trentham-Dietz A, Newcomb PA, Shoff SM. Carotenoids and risk of endometrial cancer.

Am J Epidemiol 149:S7, 1999. 75. Bertone E, Egan K, Newcomb P, Trentham-Dietz A, Stampfer M, Willett W. Intake of

carotenoids and ovarian cancer. Am J Epidemiol 149:S7, 1999. 76. Yasui Y, Newcomb P, Trentham-Dietz A, and Collaborative Breast Cancer Study II

investigators. Empirical Bayes estimates of familial risk for use in epidemiologic analyses. Am J Epidemiol 149:S56, 1999.

77. Trentham-Dietz A, Newcomb PA, Gilchrist K, Sabatini LM. Hormonal factors, p53 and

HER-2/neu status in breast cancer cases. Proc AACR 40:569, 1999. 78. Sabatini LM, Newcomb PA, Trentham-Dietz A, Gilchrist K. Interactions between p53

mutations and environmental factors in relation to breast cancer. Am J Pathol 153:1659, 1998. 79. Trentham-Dietz A, Newcomb PA, Sabatini LM, Gilchrist K. Hormone replacement therapy

and risk of postmenopausal breast cancer according to estrogen and progesterone receptor status. Proc AACR 39:101, 1998.

80. Newcomer LM, Newcomb PA, Trentham-Dietz A, Storer BE. Interactions of current

smoking status and body weight in relation to endometrial cancer risk. Am J Epidemiol 145:S69, 1997.


81. Reeves MJ, Newcomb PA, Trentham Dietz A, Remington PL. Nonsteriodal anti-

inflammatory drug use and protection against colorectal cancer in women. Am J Epidemiol 141:S65, 1995.

82. Roberts F, Newcomb P, Trentham Dietz A. Self reported stress and risk of breast cancer.

Am J Epidemiol 141:S37, 1995. 83. Mittendorf R, Longnecker MP, Newcomb P, Trentham Dietz A, Greenberg ER, Bogdan G,

Clapp R, Willett W. Strenuous physical activity in young adulthood and risk of breast cancer. Am J Epidemiol 141:S54, 1995.

ORAL PRESENTATIONS Local Invited Presentations 1. When things don’t go as planned… (panel discussion). Integrating Research Ethics and

Scholarship Spring Symposium, Wisconsin Institutes for Discovery, Madison, WI, January 2011.

2. ACCESS: Assessment of Cancer Care and Satisfaction. Grand Rounds, University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, WI, January 2009.

3. WCRS Data Utilization: Partnership with the University of Wisconsin, Goodman/Atwood

Community Center, Madison, WI, November 2008. 4. Importance of Wisconsin Cancer Registry Data in Breast Cancer Research. Wisconsin Breast

Cancer Coalition State Advocacy Day, Madison, WI, March 2008. 5. Population health and epidemiology. University of Wisconsin Paul P. Carbone Comprehensive

Cancer Center: Cancer Control Retreat, Madison, WI, May 2007. 6. ACCESS: Assessment of Cancer Care and Satisfaction. Wisconsin Cancer Council Fall

Business Meeting, 5th Annual Symposium on Advances in Multidisciplinary Cancer Care: Focusing on Palliative Care, Monona Terrace and Convention Center, Madison, WI, October 2006.

7. Epidemiology of carcinoma in situ of the breast. University of Wisconsin Population Health

Sciences Seminar. Madison, WI, April 2006. 8. Geography, environmental factors, and breast cancer. Sharing the Knowledge: Resources for

Recovery Conference. Alliant Energy Center, Madison, WI, November 2005.


9. Cancer prevention and epidemiology. University of Wisconsin Comprehensive Cancer Center:

Cancer Prevention Retreat, Madison, WI, October 2004. 10. Cancer outcomes in the Beaver Dam studies. University of Wisconsin Department of

Ophthalmology Epidemiology Group Data Analysis Meeting, Madison, WI, March 2004. 11. Breast cancer risk factors and tumor markers in Vietnamese women. International Breast

Cancer Research Foundation, Madison, WI, September 2003. 12. Epidemiologic studies of breast cancer risk at the UW. UW-Madison Breast Cancer

Minisymposium, Madison, WI, March 2001. 13. Hormones and bone fracture. University of Wisconsin Department of Ophthalmology

Epidemiology Group Data Analysis Meeting, Madison, WI, April 2000. 14. Carotenoids and risk of endometrial cancer. University of Wisconsin Department of

Ophthalmology Epidemiology Group Data Analysis Meeting, Madison, WI, June 1999. Regional Invited Presentations 1. Breast cancer in Northeast Wisconsin: Cause for Concern? Conference, Breast Health:

Empowerment & Cancer Risk Reduction. Wellness Center of Door County, Sturgeon Bay, WI, September 2011.

2. The burden of cancer in Wisconsin. Annual spring conference for the Wisconsin Environmental

Health Association, Marshfield, WI, April 2010. 3. ACCESS: Assessment of Cancer Care and Satisfaction. Wisconsin Association of Osteopathic

Physicians and Surgeons, Sheboygan, WI, November 2008. 4. Cancer Reporting System Data Utilization: Partnership with the University of Wisconsin.

Wisconsin Cancer Registrars’ Fall Conference, Waukesha Memorial Hospital Campus, Waukesha, WI, October 2003.

National Invited Presentations 1. The burden of early-staged breast cancer. University of Alabama-Birmingham School of Public

Health Epidemiology Seminar Series, Birmingham, AL, August 2009. 2. Quality of life in female colorectal cancer survivors. Long-Term Cancer Survivors: Research

Initiatives, National Cancer Institute, Rockville, MD, September 2002.


3. Statistics and Epidemiology. University of Puget Sound, Tacoma, WA, October 2000. 4. Physical activity and risk of in situ and invasive breast cancer. Wake Forest University School

of Medicine, Winston-Salem, NC, September 2000. 5. Body weight, physical activity, and risk of breast cancer. Wake Forest University School of

Medicine, Winston-Salem, NC, August 2000. 6. Body weight and risk of postmenopausal breast cancer. Division of Epidemiology Special

Seminar, University of Minnesota School of Public Health, Minneapolis, MN, January 2000. Oral Presentations Resulting from Submitted Abstracts 1. Phenol xenoestrogens and mammographic breast density. 36th Annual Meeting of the American

Society of Preventive Oncology, Washington, D.C., March 2012. Published as: Trentham-Dietz A, Sprague BL, Wang J, Hampton JM, Buist DSM, Aiello Bowles E, Sisney G, Burnside E, Hemming J, Hedman C. Cancer Epidemiol Biomarkers Prev 21(3): 561, 2012.

2. What are the risks and benefits of screening for breast cancer beginning at age 40 instead of 50? 3rd North American Congress of Epidemiology, Montreal, Canada, June 2011.

3. The impact of detection and treatment of carcinoma in situ on breast cancer mortality. 35th Annual Meeting of the American Society of Preventive Oncology, Las Vegas, NV, March 2011. Published as: Trentham-Dietz A, Sprague BL, Alagoz O, Reaidi P, Rosenberg M, Gangnon RE, Stout NK. Cancer Epidemiol Biomarkers Prev 20:720, 2011.

4. From case-control to cohort. Society for Epidemiologic Research, Anaheim, CA, June 2009.

Published as: Gangnon RE, Trentham-Dietz A. Am J Epidemiol 169(Suppl):S84, 2009 5. NSAIDs, CYP2C9 genotype, and breast cancer risk. Society for Epidemiologic Research,

Anaheim, CA, June 2009. Published as: Trentham-Dietz A, Newcomb PA, Hampton JM, Kuan L-Y, Gould MN, Makar KW. Am J Epidemiol 169:S136, 2009.

6. Risk of second breast cancer according to hormone therapy use among women with carcinoma

in situ of the breast. 32nd Annual Meeting of the American Society of Preventive Oncology, Bethesda, MD, March 2008. Published as: Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM. Cancer Epidemiol Biomarkers Prev 17(2): 460, 2008.

Prior to Promotion to Associate Professor with Tenure


7. Carcinoma in situ of the breast: true precursor or marker of increased risk? (Speaker and

symposium chair for “Intermediate markers in breast cancer: surrogates or subterfuge?”) Society for Epidemiologic Research, Boston, MA, June 2007. Published as: Trentham-Dietz A. Am J Epidemiol 165 (Suppl): S96, 2007.

8. From menarche to menopause: trends among U.S. women born 1908-1976. Society for

Epidemiologic Research, Salt Lake City, UT, June 2004. Published as: Nichols HM, Trentham-Dietz A, Hampton J, Titus-Ernstoff L, Egan K, Newcomb P. Am J Epidemiol 159: S75, 2004.

9. Physical activity and risk of breast cancer. University of Wisconsin Women’s Health Research

Colloquium, Madison, WI, November 2000. 10. Weight change and risk of postmenopausal breast cancer. University of Wisconsin Population

Health Program and Network for Health Policy Research Joint Seminar Series, Madison, WI, February 2000.

11. Weight, weight change, and risk of postmenopausal breast cancer. Society for Epidemiologic

Research, Chicago, IL, June 1998. Published as: Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Baron J, Stampfer M, Willett WC. Am J Epidemiol 147:S88, 1998.

12. Efficacy of screening mammography (dissertation results). University of Wisconsin Department

of Preventive Medicine Seminar, Madison, WI, September 1997. 13. Weight in relation to endometrial cancer risk. Society for Epidemiologic Research, Boston, MA,

June 1996. Published as: Trentham-Dietz A, Newcomb PA, Storer BE. Am J Epidemiol 143:S82, 1996.

14. Efficacy of screening mammography (dissertation methods). University of Wisconsin

Department of Preventive Medicine Seminar, Madison, WI, April 1996. 15. Multiple births and risk of breast cancer. Society for Epidemiologic Research, Snowbird, UT,

June 1995. Published as: Trentham Dietz A, Newcomb P, Storer B, Longnecker M, Mittendorf R. Am J Epidemiol 141:S16, 1995.

16. Weight change and risk of breast cancer. Epidemiologic Research Symposium, Madison, WI,

March 1995. EDUCATIONAL ACTIVITIES Medical Student Classroom Teaching, UW-Madison 2007-2013 Population Health Sciences 717 “Principles of Population Medicine and Epidemiology”


Discussion Facilitator for 4 sessions in Spring 2007, 9 sessions in Fall 2008, 7 sessions in Fall 2009, 8 sessions in Fall 2010, 10 sessions in Fall 2011, 6 sessions in Fall 2012, and 3 sessions in Fall 2013

Graduate Student Classroom Teaching, UW-Madison 2013 Population Health Sciences 805 “Epidemiology Methods 4” 2 lectures in Fall 2013 2011 Population Health Sciences 750 “Cancer Epidemiology”

Course Director in Spring 2011 2011 Nutritional Sciences 931, “Seminar”

1 lecture in Fall 2011 2009-2013 Population Health Sciences 820 “Graduate Research Seminar”

Course Co-Director in Spring 2009, Fall 2010, and Fall 2013 2005 Physician Assistant 416 “Professional Issues” 1 lecture in Spring 2005 2005 Kinesiology 508 “Epidemiology of Physical Activity” 1 lecture in Spring 2005 2003, 2004 Population Health Sciences 795 “Determinants of Population Health” 1 lecture per semester in Fall 2003, Fall 2004 2002-2006 Population Health Sciences 797 “Introduction to Epidemiology”

1 lecture per semester in Fall 2002 Course Director in Fall 2003, Fall 2004, Fall 2005, and Fall 2006

2002 Population Health Sciences 801 “Master’s Seminar” Course Co-Director in Spring 2002

2001 Population Health Sciences 901, “Seminar”

1 lecture in Fall 2001 2000-2001 Population Health Sciences 803 “Monitoring Population Health”

1 lecture per semester in Fall 2000 and Fall 2001 2000 Statistics 642 “Statistical Methods in Epidemiology” 1 lecture in Spring 2000


1999 Preventive Medicine 650 “Women's Health Epidemiology” 1 lecture in Spring 1999 1998-2012 Population Health Sciences 802 “Advanced Epidemiology: Etiology and Prevention”

1 lecture in Fall 1998 and Fall 2006 2 lectures in Fall 2002, Fall 2003, Fall 2004, Fall 2005, Fall 2009, Fall 2010, Fall 2011, and Fall 2012 Course Director in Fall 2007 and Fall 2008

Undergraduate Student Classroom Teaching, UW-Madison 2007, 2009 Population Health Sciences 375 “Introduction to Public Health” 1 lecture per semester in Spring 2007 and Spring 2009 Mentoring (starting with the most recent, senior mentees) Research Mentor, Clinical Faculty, UW-Madison 2008-present Erin Costanzo, PhD, Department of Psychiatry 2011-present K07 Mentor Committee Member 2008-2011 KL2 Mentor Committee Member 2012-present Amye Tevaarwerk, MD, Department of Medicine KL2 Mentor Committee Member 2010-2012 Jeremy Cetnar, MD, Department of Medicine American Cancer Society Institutional Research Grant Mentor Committee Member Research Mentor, Non-Clinical Faculty, UW-Madison 2008-2012 Ajay Sethi, PhD, Department of Population Health Sciences Mentor Committee Chair Postdoctoral Mentoring 2009-2010 Brian L. Sprague, PhD, UW-Madison 2008-2009 Karen Wernli, PhD, Fred Hutchinson Cancer Research Center 2004-2006 Libby Morimoto, PhD, Fred Hutchinson Cancer Research Center 2006 Miryam Schussler-Fiorenza, MD, UW-Madison


Research Mentor, Medical Students, UW-Madison 2013 Ryan Denu, Shapiro Summer Research Fellowship 2006 Mary Rhodes, Shapiro Summer Research Fellowship PhD Committee Chair, UW-Madison 2013-present Alice (Hollis) Moore, Population Health, Co-chair “Obesity, clinical guideline concordant treatment, and survival among patients with early

stage breast cancer” 2013-present Katherine Gaster, Epidemiology, Co-chair 2013-present Oyewale Shiyanbola, Epidemiology, Co-chair 2012-present Patricia Jewett, Population Health, Co-chair 2009-2013 Shaneda Warren Andersen, Population Health “Reproductive and menstrual factors, loci and breast cancer risk” Current position: Postdoctoral trainee, Vanderbilt University 2005-2009 Brian Sprague, Population Health, Epidemiology concentration “The epidemiology of breast carcinoma in situ” Current position: Assistant Professor, University of Vermont 2005-2010 Matthew Walsh, Population Health, Epidemiology concentration “Improving study validity by addressing sampling frame limitations” Current position: Associate Scientist, UW-Madison PhD Committee Member, UW-Madison 2012-present Karla Esbona, Clinical Investigation 2011-2013 Peggy Peissig, Clinical Investigation 2008-2009 Jessica Schumacher, Population Health 2004-2006 Stephanie Nelson Hesselson, Genetics 2004-2005 Kathryn Flynn, Population Health 2004-2005 Vipat Kuruchittham, Industrial Engineering 2002-2004 Natasha Stout, Population Health 2001-2006 Indiana Strombom, Population Health 2001-2004 Sigridur Gunnarsdottir, Nursing 2001-2003 Ralph Insigna, Population Health


Predoctoral Research Mentoring 2003-2011 Hazel Nichols, Johns Hopkins Bloomberg School of Public Health, Epidemiology 2002-2003 Amy Sapp, Harvard University, Epidemiology 2000-2005 Jane McElroy, UW-Madison, Environmental Studies Research Mentor, MPH/MS Graduate Students, UW-Madison 2012-present Alex Binder, Epidemiology Thesis Chair 2012 Julie Halverson, Population Health Thesis Committee Member 2011-2012 Lalita Subramanian, Capstone Project Committee Member 2011 Keith Thraen-Borowski, Kinesiology Thesis Committee Member 2010-2013 Alice (Hollis) Moore, Population Health Thesis Chair 2008-2009 Rachel Greenup, Capstone Project Chair 2008 Anna Kocharian, Population Health Thesis Committee Member 2008 Drew Roenneburg, Population Health Thesis Committee Member 2006-2008 Shaneda Warren Andersen, Population Health Thesis Chair 2006-2007 Rachel Clavers, Population Health and Psychology Thesis Committee Member 2006-2007 Brent Johnson, Population Health and Kinesiology Thesis Co-Chair 2006-2007 Timothy Wassenaar, Population Health Thesis Chair 2006 Durga Murdeshwar, Population Health and Kinesiology Thesis Committee Member 2004-2005 Gabrielle Detjen, Population Health Thesis Committee Member 2003 Hyun-Joon Park, Population Health Thesis Committee Member 2003 Priti Bandi, Population Health informal research mentor 2003 Elizabeth Dranger, Population Health informal research mentor 2002-2004 LeAnn Andersen, Population Health informal research mentor Course Advisor, PhD/MS Graduate Students, UW-Madison 2009-2010 Sridevi Mohan, Population Health 2007-2012 Steph Karpinski, Population Health 2006-2008 Anna Kocharian, Population Health 2002 Joe Leonard, Population Health 2001-2004 Mark Zehner, Population Health 2001-2004 Tara Breslin, MD, Population Health Research Mentor, Undergraduate Students 2013 Veronica Burt, Grand Valley State University, Biostatistics

Computational Biology and Biostatistics Summer Research Program


2011 Suzanne Nelson, California Polytechnic State University, Biostatistics

Computational Biology and Biostatistics Summer Research Program 2009 Ritesh Ramchandani, University of Florida, Biostatistics

Computational Biology and Biostatistics Summer Research Program 2001 Kristin Block, Beloit College, Cellular and Molecular Biology

Summer research undergraduate intern SERVICE ACTIVITIES Department of Population Health Sciences, University of Wisconsin-Madison 2013-2014 Member, Joint BMI/PHS Faculty Search Committee 2012-present Chair, Admissions Committee, Graduate Program in Epidemiology 2012-present Member, Steering Committee, Graduate Program in Epidemiology 2011-present Curriculum Committee, Graduate Program in Population Health 2009 Merit and Review Committee 2007-2009 Chair, Qualifier Examination Committee, Population Health Program 2005-2006 Member, Health Policy Faculty Search Committee 2004-2005 Qualifier Examination Committee, Population Health Program 2004 Strategic Plan Committee 2003-2007 Senator, Faculty Senate 2002-2009 Department Environment Committee 2002-2006 Space Committee 2002 Administrative Structure Review Committee School of Medicine and Public Health, University of Wisconsin-Madison 2013-present Member, Basic Sciences in Medical and Professional Student Education Work Group 2012-present Member, Protocol Review and Monitoring Committee, Carbone Cancer Center 2012-2013 Member, Annual Retreat Program Planning Committee, Carbone Cancer Center 2011-present Reviewer, Investigator Initiated Pilot Projects, Carbone Cancer Center 2009-present Faculty Supervisor, Survey Research Shared Resource, Carbone Cancer Center 2009 Reviewer, Type 2 Translational Grant Program, Institute for Clinical and Translational

Research (ICTR) 2009 Cancer Data Advisory Group, Comprehensive Cancer Control Program 2008 Reviewer, New Investigator Grants Program, Medical Education and Research

Committee 2007-2012 Member, Health Sciences Minimal Risk Human Subjects Committee National Professional Service, ad hoc Manuscript Reviewer for Journals


American Journal of Epidemiology Annals of Epidemiology Breast Cancer Research Breast Cancer Research and Treatment Cancer Cancer Research Cancer Causes and Control Cancer Epidemiology Biomarkers and Prevention European Journal of Cancer Hormones and Cancer International Journal of Cancer International Journal of Epidemiology International Journal of Obesity and Related Metabolic Disorders Journal of Cancer Epidemiology Journal of the American Medical Association Journal of the National Cancer Institute Maturitas New England Journal of Medicine The Oncologist Psycho-Oncology Quality of Life Research Sleep Other National Professional Service 2013 Reviewer, Breast Cancer Research Foundation Fellowship, American Society for

Preventive Oncology 2012-present Member-At-Large, Executive Committee, American Society for Preventive Oncology 2012, 2013 Annual Meeting Program Planning Committee, Breast Cancer and the Environment

Research Program 2011-present Study section member, EPIC (Epidemiology of Cancer) Study Section, NIH 2010-2011 Reviewer, Postdoctoral Fellowship - Disparities Research Grants, Susan G. Komen for

the Cure Breast Cancer Foundation 2009-present Editorial Board Member, Cancer Epidemiology Biomarkers & Prevention 2009-2010 ad hoc Reviewer, EPIC (Epidemiology of Cancer) Study Section, NIH 2009 Reviewer, Breast Cancer Training Clinical & Experimental Therapeutics Panel,

Department of Defense Breast Cancer Research Program 2008, 2013 Reviewer, R13 Conference Grants Special Emphasis Panel, NIH 2008-present ex officio, Annual Meeting Program Planning Committee, American Society for

Preventive Oncology 2008 Reviewer, Nutritional, Behavioral, and Lifestyle Prevention (NBLP) Study Section,


Susan G. Komen for the Cure Breast Cancer Foundation

2007 Reviewer, Nancy R. Gelman Foundation Seed Grants 2005-2006 Reviewer, Cancer Prevention Research Foundation Fellowship, American Society for

Preventive Oncology 2004-2010, 2012-2014 Annual meeting abstract reviewer, Society for Epidemiologic Research 2004-2012 Treasurer, Executive Committee, American Society for Preventive Oncology 2002-2003 Junior Members Interest Group Representative, Executive Committee, American

Society for Preventive Oncology 2001 Annual Meeting Program Planning Committee, American Society for Preventive

Oncology

3/1/2014


AMY TRENTHAM-DIETZ, PHD, MS - Population Health … TRENTHAM-DIETZ, PHD, MS . PERSONAL DATA ... Amy...

Documents

Transcript of AMY TRENTHAM-DIETZ, PHD, MS - Population Health … TRENTHAM-DIETZ, PHD, MS . PERSONAL DATA ... Amy...